A thorough understanding of the development process for novel compounds and the phases of preclinical and clinical testing are a prerequisite for a successful scientific career in the field of drug development. The conduct of preclinical and clinical trials demands a high level of professionalism and only high quality research will allow establishing more effective and safer treatment strategies for patients in the future.
The doctoral program of applied science "Preclinical and clinical research in drug development" will provide a comprehensive training in all major areas of patient-orientated research in drug development. The candidates will be familiarized with the theoretical background of development of a novel compound beginning from the screening in in vitro via preclinical animal models up to clinical trial testing ("form bench to bedside"). The main focus will be on the methodology and conduct of preclinical - and clinical trials according to the guidelines of "Good Clinical Practice" (GCP).
Embedded in interdisciplinary research teams with medics, study nurses, molecular biologists and chemists the candidates will plan, design and implement their research projects with scientific integrity in the research areas of infectiology, cardiovascular medicine, hematology and immunology, experimental oncology, emergency medicine, ophthalmology, pediatrics, pharmacogenetics or imaging.
Knowledge of numerous biomedical methods and their application in medical research and practice will be teached. Thus, candidates graduating from the doctoral program of applied science "Preclinical and clinical research in drug development" will be skilled to apply their theoretical and practical qualifications in high standard clinical research projects within an academic and professional context.